D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 93 Citations 44,363 284 World Ranking 335 National Ranking 173
Medicine D-index 97 Citations 49,130 319 World Ranking 5500 National Ranking 3050

Research.com Recognitions

Awards & Achievements

2014 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Virus
  • Cancer

Jules L. Dienstag focuses on Internal medicine, Gastroenterology, Immunology, Hepatitis B virus and Hepatitis C. His study on Internal medicine is mostly dedicated to connecting different topics, such as Ribavirin. The concepts of his Gastroenterology study are interwoven with issues in Interferon and Surgery.

His Immunology and Hepatitis, Viral disease, Hepatitis C virus, Antibody and Human leukocyte antigen investigations all form part of his Immunology research activities. Hepatitis B virus is a subfield of Virology that Jules L. Dienstag explores. The Hepatitis C study combines topics in areas such as Pegylated interferon and Maintenance therapy.

His most cited work include:

  • An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis (3065 citations)
  • Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States (1612 citations)
  • Viral Hepatitis and Liver Disease (1435 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Immunology, Internal medicine, Virology, Hepatitis and Gastroenterology. His work on Immunology deals in particular with Hepatitis B, Antibody, Hepatitis B virus, HBsAg and Viral disease. His Internal medicine research is multidisciplinary, incorporating elements of Ribavirin and Surgery.

His Virology research integrates issues from Serology and Antigen. The various areas that Jules L. Dienstag examines in his Hepatitis study include Chronic liver disease and Outbreak. His work carried out in the field of Gastroenterology brings together such families of science as Interferon, Liver transplantation, Liver biopsy and Pathology.

He most often published in these fields:

  • Immunology (42.01%)
  • Internal medicine (38.87%)
  • Virology (35.42%)

What were the highlights of his more recent work (between 2005-2021)?

  • Internal medicine (38.87%)
  • Gastroenterology (26.96%)
  • Hepatitis C (18.81%)

In recent papers he was focusing on the following fields of study:

Jules L. Dienstag mostly deals with Internal medicine, Gastroenterology, Hepatitis C, Cirrhosis and Immunology. Many of his studies involve connections with topics such as Ribavirin and Internal medicine. His research on Gastroenterology also deals with topics like

  • Viral hepatitis which is related to area like HBsAg,
  • Alpha interferon that intertwine with fields like Hepacivirus.

His Hepatitis C study combines topics in areas such as Surgery, Fibrosis, Biopsy, Pathology and Hepatocellular carcinoma. In Cirrhosis, Jules L. Dienstag works on issues like Hepatitis C virus, which are connected to Viral load. As part of his studies on Immunology, Jules L. Dienstag frequently links adjacent subjects like Drug resistance.

Between 2005 and 2021, his most popular works were:

  • Hepatitis B Virus Infection (751 citations)
  • Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease (470 citations)
  • Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon (414 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Virus
  • Cancer

His scientific interests lie mostly in Internal medicine, Hepatitis C, Cirrhosis, Gastroenterology and Hepatocellular carcinoma. The concepts of his Internal medicine study are interwoven with issues in Immunology and Oncology. His work deals with themes such as Randomized controlled trial and Pathology, which intersect with Hepatitis C.

His Cirrhosis study integrates concerns from other disciplines, such as Ribavirin, Hepatitis C virus, Maintenance therapy, Hepatitis and Hepatology. His Gastroenterology research incorporates elements of Viral hepatitis, Liver biopsy, Fibrosis and Surgery. Jules L. Dienstag works mostly in the field of Hepatitis B, limiting it down to concerns involving Adverse effect and, occasionally, Hepatitis B virus.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

G. Kuo;Q.-L. Choo;H.J. Alter;G.L. Gitnick.
Science (1989)

4451 Citations

Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States

George Ostapowicz;Robert J. Fontana;Frank V. Schioødt;Anne Larson.
Annals of Internal Medicine (2002)

2540 Citations

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.

Davis Gl;Balart La;Schiff Er;Lindsay K.
The New England Journal of Medicine (1989)

2454 Citations

Viral Hepatitis and Liver Disease

Girish N. Vyas;Jules Dienstag;Jay H. Hoofnagle.
(1985)

2304 Citations

Lamivudine as initial treatment for chronic hepatitis B in the United States.

Jules L. Dienstag;Eugene R. Schiff;Teresa L. Wright;Robert P. Perrillo.
The New England Journal of Medicine (1999)

1958 Citations

Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C

John G. McHutchison;Michael Manns;Keyur Patel;Thierry Poynard.
Gastroenterology (2002)

1318 Citations

A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection

Jules L. Dienstag;Robert P. Perrillo;Eugene R. Schiff;Maria Bartholomew.
The New England Journal of Medicine (1995)

1211 Citations

Hepatitis B Virus Infection

Jules L. Dienstag.
The New England Journal of Medicine (2008)

1204 Citations

Long-term safety of lamivudine treatment in patients with chronic hepatitis B.

Anna S.F. Lok;Ching Lung Lai;Nancy Leung;Guang Bi Yao.
Gastroenterology (2003)

1187 Citations

A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis B

Robert P. Perrillo;Eugene R. Schiff;Gary L. Davis;Henry C. Bodenheimer.
The New England Journal of Medicine (1990)

1185 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jules L. Dienstag

Fabien Zoulim

Fabien Zoulim

Inserm

Publications: 132

William M. Lee

William M. Lee

The University of Texas Southwestern Medical Center

Publications: 132

Hiromitsu Kumada

Hiromitsu Kumada

Fukuoka University

Publications: 119

Stephen Locarnini

Stephen Locarnini

Melbourne Health

Publications: 109

Patrick Marcellin

Patrick Marcellin

Université Paris Cité

Publications: 109

Robert H. Purcell

Robert H. Purcell

National Institute of Allergy and Infectious Diseases

Publications: 103

Robert J. Fontana

Robert J. Fontana

University of Michigan–Ann Arbor

Publications: 99

Michael P. Manns

Michael P. Manns

Hannover Medical School

Publications: 97

Stefan Zeuzem

Stefan Zeuzem

Goethe University Frankfurt

Publications: 95

Jay H. Hoofnagle

Jay H. Hoofnagle

National Institutes of Health

Publications: 92

Raymond T. Chung

Raymond T. Chung

Harvard University

Publications: 89

Ching-Lung Lai

Ching-Lung Lai

University of Hong Kong

Publications: 89

Christian Trepo

Christian Trepo

Hospices Civils de Lyon

Publications: 89

Ding-Shinn Chen

Ding-Shinn Chen

National Taiwan University

Publications: 87

Yasuji Arase

Yasuji Arase

University of Yamanashi

Publications: 85

Mitchell L. Shiffman

Mitchell L. Shiffman

Bon Secours Health System

Publications: 84

Trending Scientists

Roy Rothwell

Roy Rothwell

University of Sussex

Nenghai Yu

Nenghai Yu

University of Science and Technology of China

Eugene L. Timperman

Eugene L. Timperman

Johnson & Johnson (United States)

Sheo B. Singh

Sheo B. Singh

MSD (United States)

Dmitri G. Fedorov

Dmitri G. Fedorov

National Institute of Advanced Industrial Science and Technology

Jian Fan

Jian Fan

Soochow University

Ling-Dong Sun

Ling-Dong Sun

Peking University

Hiroshi Kawasaki

Hiroshi Kawasaki

Keio University

Robert D. Hatcher

Robert D. Hatcher

University of Tennessee at Knoxville

Carlo Giupponi

Carlo Giupponi

Ca Foscari University of Venice

Karyn M. Frick

Karyn M. Frick

University of Wisconsin–Milwaukee

Muriel Moser

Muriel Moser

Université Libre de Bruxelles

Ger T. Rijkers

Ger T. Rijkers

University College Roosevelt

Daniel T. L. Shek

Daniel T. L. Shek

Hong Kong Polytechnic University

David M. Jacobowitz

David M. Jacobowitz

National Institutes of Health

Michael W. Bauer

Michael W. Bauer

German University of Administrative Sciences

Something went wrong. Please try again later.